Xcout Intel
BTB Therapeutics, Inc.
BTB Therapeutics, Inc. is a Delaware C-corp. that completed a US corporate inversion in January 2025 and is located in Escondido, California, with an operating subsidiary in Kyoto, Japan.
Subscribe to see BTB Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
BTB Therapeutics, Inc. at a glance
BTB Therapeutics, Inc. is a company headquartered in United States. It has raised at least $12.2M across the 2 funding rounds on record. Its most recent funding round raised $8.9M in November 2025. Xcout tracks 8 named people at BTB Therapeutics, Inc., including Takashi Kiyoizumi (CEO, Director of the Board BTB Therapeutics GK CEO).
BTB Therapeutics, Inc. leadership
- Takashi KiyoizumiCEO, Director of the Board BTB Therapeutics GK CEO
- Kenneth W. LockeChief Development Officer
- Masatoshi HagiwaraChief Scientific Officer, Director of the Board
- Takashi KiyoizumiExecutive Officer
- David R SnyderDirector of the Board
- David SnyderDirector
2 more named people on record for BTB Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
BTB Therapeutics, Inc. funding rounds
At least $12.2M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $8.9M | — | |
| SEC Form D filing | $3.3M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent BTB Therapeutics, Inc. news
- FundingPrivate placement (Form D)
BTB Therapeutics, Inc. competitors
A few of BTB Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
TBT Pharma, Inc. is a pharmaceutical research and development company founded in 2019 and headquartered in Baltimore, Maryland.
BridgeBio Oncology Therapeutics (BBOT) is a biotechnology company focused on oncology therapeutics under its 'Best-in-RAS' initiative. The company maintains its corporate headquarters in South San Francisco, California.
Gemini Therapeutics, Inc. is a biotechnology company incorporated in Delaware that maintains a corporate mailing address in Wayland, Massachusetts.
Kinnate Biopharma Inc. is a precision oncology company incorporated in Delaware and headquartered in San Diego, California, focused on advancing targeted therapies.
Turning Point Therapeutics is a clinical-stage precision oncology company based in San Diego, California, that designs and develops targeted cancer therapies. Founded in 2013, the company operates as a subsidiary of Bristol Myers Squibb following its acquisition in 2022.
Basilard BioTech, Inc. is a biotechnology company founded in 2019 to research and develop novel therapeutic technologies. Headquartered in Southern California, United States, the company operates within the life sciences sector.
Get BTB Therapeutics, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on BTB Therapeutics, Inc. in Xcout Intel
- 8 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access